FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

(Reuters) – AstraZeneca Plc AZN.L said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.

AstraZeneca on Saturday published a document describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times.

Reporting by Rama Venkat in Bengaluru; Editing by Michael Perry

Via Reuters Finance

READ ALSO  Netflix turns to telecoms tie-ups in challenging African markets